Medication use and major depressive syndrome in a community population

被引:40
作者
Patten, SB [1 ]
Lavorato, DH
机构
[1] Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 4N1, Canada
[2] Univ Calgary, Dept Psychiat, Calgary, AB T2N 4N1, Canada
[3] Alberta Heritage Fdn Med Res, Calgary, AB, Canada
关键词
D O I
10.1053/comp.2001.21218
中图分类号
R749 [精神病学];
学科分类号
100205 [精神病与精神卫生学];
摘要
A variety of medications have been reported to cause depression as a side effect. This study evaluated cross-sectional associations between a variety of medications and a syndrome resembling major depression. A sample of 2,542 subjects were selected using the Mitofsky-Waksberg random digit dialing (RDD) procedure. Major depression was evaluated using a short form version of the Composite International Diagnostic Interview (CIDI). Current medication use was recorded during the same telephone interview. Statistical methods accounting for clustering and unequal selection probabilities were employed. Most medications were not associated with major depression: these included beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, lipid-lowering agents, digoxin, and diuretics. Calcium channel blockers were significantly associated with major depression, but only in a subset of young subjects, and these tended to be seriously ill individuals taking multiple medications. Opiate analgesics were associated with major depression, but only in male subjects. Corticosteroids were significantly associated with major depression in a logistic regression model that adjusted for age and gender. The cross-sectional nature of this study precludes causal inference about the observed associations. With the exception of the association of major depression with corticosteroid use, convincing associations with other medications were not observed. It is possible that medication-induced depressive episodes lead to changes in exposure status (such as discontinuation of the offending medications) such that the associations are not apparent in cross-sectional data. If this interpretation is correct, these data suggest that the problem of medication-induced depression is being managed effectively at the clinical level and is not a substantial public health problem. Copyright (C) 2001 by W.B. Saunders Company.
引用
收藏
页码:124 / 131
页数:8
相关论文
共 45 条
[1]
ELEVATION OF BETA-ADRENERGIC-RECEPTOR DENSITY IN HUMAN-LYMPHOCYTES AFTER PROPRANOLOL ADMINISTRATION [J].
AARONS, RD ;
NIES, AS ;
GAL, J ;
HEGSTRAND, LR ;
MOLINOFF, PB .
JOURNAL OF CLINICAL INVESTIGATION, 1980, 65 (05) :949-957
[2]
INCREASED ANTIDEPRESSANT USE IN PATIENTS PRESCRIBED BETA-BLOCKERS [J].
AVORN, J ;
EVERITT, DE ;
WEISS, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 255 (03) :357-360
[3]
Baum C, 1994, PHARMACOEPIDEM DR S, P125
[4]
BUNNEY WE, 1965, ARCH GEN PSYCHIAT, V13, P483
[5]
*CDCP WHO, 1997, EP INF
[7]
COLLET JP, 1994, PHARMACOEPIDEM DR S, P609
[8]
CREMONABARBARO A, 1983, LANCET, V1, P185
[10]
Gillis MC, 1998, COMPENDIUM PHARM SPE